HSP90AA1 and colorectal cancer: In our previous study, we designed a series of dual HDAC/HSP90 inhibitors; in particular, MPT0G449 (compound 26) showed cytotoxicity in lung and colorectal cancer cells and higher selectivity for HDAC and HSP90 enzyme inhibition30.